LI
CRL icon

Louisbourg Investments’s Charles River Laboratories CRL Stock Holding History

Louisbourg Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10
Closed -$2K – 218
2025
Q4 		$2K Hold
10
– – ﹤0.01% 193
2025
Q3 		$1.56K Hold
10
– – ﹤0.01% 192
2025
Q2 		$1.52K Hold
10
– – ﹤0.01% 187
2025
Q1 		$1.5K Buy
+10
New +$1.68K ﹤0.01% 166

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Louisbourg Investments's CRL Position: Q1 2026 in Review

Louisbourg Investments sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 10 shares — an estimated $2K sold.

Louisbourg Investments first reported a position in CRL in Q1 2025 and held it in 4 quarters. The position peaked at $2K in Q4 2025. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Louisbourg Investments reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
  • Louisbourg Investments sold 10 Charles River Laboratories shares in Q1 2026, an estimated $2K.
  • Louisbourg Investments first reported a position in Charles River Laboratories in Q1 2025 and held it in 4 quarters.
  • Louisbourg Investments's Charles River Laboratories position peaked at $2K in Q4 2025.
  • 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Louisbourg Investments's 13F filing for Q1 2026, filed 22 Apr 2026.